SanBio Company
SanBio is a regenerative medicine company.
.jpeg)
Technology:
Regenerative Medicine, Stem cell therapy
Industry:
Cell Therapy, Public
Headquarters:
Tokyo, Tokyo, Japan
Founded Date:
2013-02-27
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
6
Total Funding:
48289182
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-01-01
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership